• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX, INC. AFX 2; BIFURCATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX, INC. AFX 2; BIFURCATED Back to Search Results
Model Number BEA22-90/I16-30, AFX2
Device Problems Failure To Adhere Or Bond (1031); Partial Blockage (1065); Collapse (1099); Leak/Splash (1354); Device Damaged Prior to Use (2284); Unintended Movement (3026)
Patient Problems Failure of Implant (1924); Thrombus (2101); Stenosis (2263); Claudication (2550)
Event Date 05/06/2016
Event Type  Injury  
Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
It was reported that during the initial implant on (b)(6) 2016, the physician noted that the bifurcated device was partially deployed in the package.He was able to use the device to complete the procedure.Subsequently, on (b)(6) 2016, the patient returned to the hospital emergently with a stent migration, stenosis, and deformity with a type ia endoleak.The next day, on (b)(6) 2016, the physician used competitor balloon and stent to correct the issue.Patient tolerated the surgery well.
 
Manufacturer Narrative
At the completion of the investigation, based on the information provided, the clinical evaluation was able to confirm the type 1a endoleak and stent collapse.The clinical evaluation was not able to confirm the reported stent migration.The clinical evaluation additionally identified the following contributing factors to the reported event; off label use, use of partially deployed stent, development of the inner stent thrombus and patent lumbar arteries prior to initial implant.The manufacturing evaluation did not reveal any issues or deviations that would explain the reported event.The manufacturing lot evaluation confirmed all devices met specifications prior to release.The event devices remain implanted in the patient and were not available for further evaluation.The root cause of the reported event is unknown.There is not enough information available to determine the root cause of the reported event.There have been no additional adverse events reported for this patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX 2
Type of Device
BIFURCATED
Manufacturer (Section D)
ENDOLOGIX, INC.
2 musick
irvine CA 92618
Manufacturer Contact
tahereh sedighi
2 musick
irvine, CA 92618
9495984671
MDR Report Key5697495
MDR Text Key46497200
Report Number2031527-2016-00260
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009015136
UDI-Public(01)00818009015136(17)170311
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
PO40002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/09/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/03/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/11/2017
Device Model NumberBEA22-90/I16-30, AFX2
Device Lot Number1356221-025
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/08/2016
Was Device Evaluated by Manufacturer? No
Date Device Manufactured03/29/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
Patient Weight96
-
-